Literature DB >> 24443660

Preliminary long-term follow-up of Mindfulness-based cognitive therapy-induced remission of depression.

Krishna Munshi1, Stuart Eisendrath2, Kevin Delucchi3.   

Abstract

Major depressive disorder (MDD) is often chronic and characterized by relapse and recurrence despite successful treatments to induce remission. Mindfulness-based cognitive therapy (MBCT) was developed as a means of preventing relapse for individuals in remission using cognitive interventions. In addition, MBCT has preliminarily been found to be useful in treating active depression. This current investigation is unique in evaluating the long-term outcome of individuals with active depression who achieved remission with MBCT. 18 participants who achieved remission after an 8-week MBCT group were seen for evaluation at a mean follow-up interval of 48.7 months (SD=10.2) after completing treatment. The current study shows that in these participants, the gains achieved after the initial treatment including remission of depression, decreased rumination, decreased anxiety, and increased mindfulness continued for up to 58.9 months of follow-up. The data suggests that all levels of depression from less recurrent and mild to more recurrent and severe were responsive to MBCT. The average number of minutes per week of continued practice in our cohort was 210, but the number of minutes of practice did not correlate with depression outcomes. MBCT's effects may be more related to regularity of practice than specific quantity. This study provides a preliminary exploration of MBCT's long-term effects, which can aid in future research with a typically chronic illness.

Entities:  

Keywords:  MBCT; Mindfulness-Based Cognitive Therapy; depression; long-term; prevention; relapse; remission

Year:  2013        PMID: 24443660      PMCID: PMC3891780          DOI: 10.1007/s12671-012-0135-0

Source DB:  PubMed          Journal:  Mindfulness (N Y)        ISSN: 1868-8527


  32 in total

1.  Cognitive-behavioral management of drug-resistant major depressive disorder.

Authors:  G A Fava; G Savron; S Grandi; C Rafanelli
Journal:  J Clin Psychiatry       Date:  1997-06       Impact factor: 4.384

2.  Mindfulness-based cognitive therapy vs cognitive behaviour therapy as a treatment for non-melancholic depression.

Authors:  Vijaya Manicavasgar; Gordon Parker; Tania Perich
Journal:  J Affect Disord       Date:  2010-11-20       Impact factor: 4.839

3.  The effects of mindfulness-based cognitive therapy on recurrence of depressive episodes, mental health and quality of life: A randomized controlled study.

Authors:  K A Godfrin; C van Heeringen
Journal:  Behav Res Ther       Date:  2010-04-18

4.  Psychosocial disability during the long-term course of unipolar major depressive disorder.

Authors:  L L Judd; H S Akiskal; P J Zeller; M Paulus; A C Leon; J D Maser; J Endicott; W Coryell; J L Kunovac; T I Mueller; J P Rice; M B Keller
Journal:  Arch Gen Psychiatry       Date:  2000-04

5.  Treatment-resistant depressed patients show a good response to Mindfulness-based Cognitive Therapy.

Authors:  M A Kenny; J M G Williams
Journal:  Behav Res Ther       Date:  2006-06-23

Review 6.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

7.  Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects.

Authors:  S Helen Ma; John D Teasdale
Journal:  J Consult Clin Psychol       Date:  2004-02

8.  [Long-term treatment of depression: there is more than drugs].

Authors:  Giovanni Andrea Fava; Chiara Ruini
Journal:  Recenti Prog Med       Date:  2002-06

9.  Psychological benefits for cancer patients and their partners participating in mindfulness-based stress reduction (MBSR).

Authors:  Kathryn Birnie; Sheila N Garland; Linda E Carlson
Journal:  Psychooncology       Date:  2010-09       Impact factor: 3.894

10.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06
View more
  6 in total

1.  Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition.

Authors:  Amanda J Shallcross; James J Gross; Pallavi D Visvanathan; Niketa Kumar; Amy Palfrey; Brett Q Ford; Sona Dimidjian; Stephen Shirk; Jill Holm-Denoma; Kari M Goode; Erica Cox; William Chaplin; Iris B Mauss
Journal:  J Consult Clin Psychol       Date:  2015-08-10

Review 2.  Prospects for a clinical science of mindfulness-based intervention.

Authors:  Sona Dimidjian; Zindel V Segal
Journal:  Am Psychol       Date:  2015-10

3.  "Pain Can't Stop Me": Examining Pain Self-Efficacy and Acceptance as Resilience Processes Among Youth With Chronic Headache.

Authors:  Sreeja Kalapurakkel; Elizabeth A Carpino; Alyssa Lebel; Laura E Simons
Journal:  J Pediatr Psychol       Date:  2014-10-15

4.  Relapse/Recurrence Prevention in Major Depressive Disorder: 26-Month Follow-Up of Mindfulness-Based Cognitive Therapy Versus an Active Control.

Authors:  Amanda J Shallcross; Emily C Willroth; Aaron Fisher; Sona Dimidjian; James J Gross; Pallavi D Visvanathan; Iris B Mauss
Journal:  Behav Ther       Date:  2018-02-08

Review 5.  Mindfulness-based therapies in the treatment of functional gastrointestinal disorders: a meta-analysis.

Authors:  Monique Aucoin; Marie-Jasmine Lalonde-Parsi; Kieran Cooley
Journal:  Evid Based Complement Alternat Med       Date:  2014-09-11       Impact factor: 2.629

6.  The development of an RDoC-based treatment program for adolescent depression: "Training for Awareness, Resilience, and Action" (TARA).

Authors:  Eva Henje Blom; Larissa G Duncan; Tiffany C Ho; Colm G Connolly; Kaja Z LeWinn; Margaret Chesney; Frederick M Hecht; Tony T Yang
Journal:  Front Hum Neurosci       Date:  2014-08-19       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.